1. Home
  2. STKH vs XBIO Comparison

STKH vs XBIO Comparison

Compare STKH & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • XBIO
  • Stock Information
  • Founded
  • STKH 2018
  • XBIO N/A
  • Country
  • STKH Israel
  • XBIO United States
  • Employees
  • STKH N/A
  • XBIO N/A
  • Industry
  • STKH Packaged Foods
  • XBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKH Consumer Staples
  • XBIO Health Care
  • Exchange
  • STKH Nasdaq
  • XBIO Nasdaq
  • Market Cap
  • STKH 4.9M
  • XBIO 4.2M
  • IPO Year
  • STKH 2021
  • XBIO N/A
  • Fundamental
  • Price
  • STKH $2.86
  • XBIO $2.91
  • Analyst Decision
  • STKH
  • XBIO Hold
  • Analyst Count
  • STKH 0
  • XBIO 1
  • Target Price
  • STKH N/A
  • XBIO N/A
  • AVG Volume (30 Days)
  • STKH 132.6K
  • XBIO 9.5K
  • Earning Date
  • STKH 03-31-2025
  • XBIO 05-13-2025
  • Dividend Yield
  • STKH N/A
  • XBIO N/A
  • EPS Growth
  • STKH N/A
  • XBIO N/A
  • EPS
  • STKH N/A
  • XBIO N/A
  • Revenue
  • STKH $10,000.00
  • XBIO $2,582,728.00
  • Revenue This Year
  • STKH N/A
  • XBIO $14.23
  • Revenue Next Year
  • STKH N/A
  • XBIO N/A
  • P/E Ratio
  • STKH N/A
  • XBIO N/A
  • Revenue Growth
  • STKH N/A
  • XBIO 5.63
  • 52 Week Low
  • STKH $0.60
  • XBIO $2.20
  • 52 Week High
  • STKH $4.64
  • XBIO $5.20
  • Technical
  • Relative Strength Index (RSI)
  • STKH 35.98
  • XBIO 49.56
  • Support Level
  • STKH $2.70
  • XBIO $2.78
  • Resistance Level
  • STKH $3.17
  • XBIO $3.22
  • Average True Range (ATR)
  • STKH 0.28
  • XBIO 0.24
  • MACD
  • STKH 0.07
  • XBIO 0.03
  • Stochastic Oscillator
  • STKH 18.18
  • XBIO 34.16

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: